Critical evaluation of drug promotional literature for drugs used in cardiovascular diseases

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: This study was conducted to critically evaluate the drug promotional literature pertaining to drugs used in cardiovascular disorders using WHO criteria for ethical promotion of drugs. Methods: The brochures were collected from physicians to whom it was circulated by the pharmaceutical representatives. These promotional literatures are tested against WHO criteria for the ethical medicinal drug promotion. Results: A total of 309 drug promotional literature pertaining to cardiovascular drugs collected. Analysis of these literatures showed that none of the promotional literature fulfilled all the WHO criteria. All the materials mentioned INN and the brand name of the product. The criteria presented least were information about adjuvants, overdosage and cost of the drug. Conclusion: None of the promotional literatures fulfilled all the WHO criteria laid down for the ethical promotion of drugs.

Original languageEnglish
Pages (from-to)405-407
Number of pages3
JournalInternational Journal of Pharmacy and Pharmaceutical Sciences
Volume7
Issue number4
Publication statusPublished - 01-01-2015

Fingerprint

Drug Evaluation
Cardiovascular Diseases
Pharmaceutical Preparations
Cardiovascular Agents
Pamphlets
Drug Costs
Names
Physicians

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

@article{ca5b1bd1f0454ebe8a36c7b1b41a931e,
title = "Critical evaluation of drug promotional literature for drugs used in cardiovascular diseases",
abstract = "Objective: This study was conducted to critically evaluate the drug promotional literature pertaining to drugs used in cardiovascular disorders using WHO criteria for ethical promotion of drugs. Methods: The brochures were collected from physicians to whom it was circulated by the pharmaceutical representatives. These promotional literatures are tested against WHO criteria for the ethical medicinal drug promotion. Results: A total of 309 drug promotional literature pertaining to cardiovascular drugs collected. Analysis of these literatures showed that none of the promotional literature fulfilled all the WHO criteria. All the materials mentioned INN and the brand name of the product. The criteria presented least were information about adjuvants, overdosage and cost of the drug. Conclusion: None of the promotional literatures fulfilled all the WHO criteria laid down for the ethical promotion of drugs.",
author = "D. Saibhavana and Chowta, {Mukta N.} and Chowta, {Nithyananda K.}",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "7",
pages = "405--407",
journal = "International Journal of Pharmacy and Pharmaceutical Sciences",
issn = "0975-1491",
publisher = "IJPPS",
number = "4",

}

TY - JOUR

T1 - Critical evaluation of drug promotional literature for drugs used in cardiovascular diseases

AU - Saibhavana, D.

AU - Chowta, Mukta N.

AU - Chowta, Nithyananda K.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objective: This study was conducted to critically evaluate the drug promotional literature pertaining to drugs used in cardiovascular disorders using WHO criteria for ethical promotion of drugs. Methods: The brochures were collected from physicians to whom it was circulated by the pharmaceutical representatives. These promotional literatures are tested against WHO criteria for the ethical medicinal drug promotion. Results: A total of 309 drug promotional literature pertaining to cardiovascular drugs collected. Analysis of these literatures showed that none of the promotional literature fulfilled all the WHO criteria. All the materials mentioned INN and the brand name of the product. The criteria presented least were information about adjuvants, overdosage and cost of the drug. Conclusion: None of the promotional literatures fulfilled all the WHO criteria laid down for the ethical promotion of drugs.

AB - Objective: This study was conducted to critically evaluate the drug promotional literature pertaining to drugs used in cardiovascular disorders using WHO criteria for ethical promotion of drugs. Methods: The brochures were collected from physicians to whom it was circulated by the pharmaceutical representatives. These promotional literatures are tested against WHO criteria for the ethical medicinal drug promotion. Results: A total of 309 drug promotional literature pertaining to cardiovascular drugs collected. Analysis of these literatures showed that none of the promotional literature fulfilled all the WHO criteria. All the materials mentioned INN and the brand name of the product. The criteria presented least were information about adjuvants, overdosage and cost of the drug. Conclusion: None of the promotional literatures fulfilled all the WHO criteria laid down for the ethical promotion of drugs.

UR - http://www.scopus.com/inward/record.url?scp=84928658980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928658980&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 405

EP - 407

JO - International Journal of Pharmacy and Pharmaceutical Sciences

JF - International Journal of Pharmacy and Pharmaceutical Sciences

SN - 0975-1491

IS - 4

ER -